Characterization of crosslinked high amylose starch matrix implants: 1. In vitro release of ciprofloxacin
- 18 July 2002
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 82 (1) , 83-93
- https://doi.org/10.1016/s0168-3659(02)00133-5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Characterization of subcutaneous Contramid implantation: host response and delivery of a potent analog of the growth hormone-releasing factor.International Journal of Pharmaceutics, 2002
- Tissue reaction and biodegradation of implanted cross‐linked high amylose starch in ratsJournal of Biomedical Materials Research, 2002
- Release profile of antimicrobial agents from α-tricalcium phosphate cementBiomaterials, 2001
- Distribution and binding kinetics of ciprofloxacin and ofloxacin in the hindlimb of the rat.Pharmaceutical Research, 1999
- Use of quinolones in osteomyelitis and infected orthopaedic prosthesis.Drugs, 1999
- Cross-linked high amylose starch for controlled release of drugs: recent advancesJournal of Controlled Release, 1998
- Future Management of Serious Infections with QuinolonesClinical Drug Investigation, 1998
- In Vitro Release of New Quinolones from Biodegradable Systems: A Comparative StudyJournal of Biomaterials Applications, 1996
- In vitro elution of ciprofloxacin from polymethylmethacrylate cement beadsJournal of Orthopaedic Research, 1994
- Controlled release of theophylline from cross-linked amylose tabletsJournal of Controlled Release, 1991